Branchiogenic Deafness Syndrome

Branchiogenic deafness syndrome is a very rare condition present from birth. It affects parts of the neck that come from the second branchial arch (a structure that forms early in the embryo) and it affects the ears. Children are born with abnormal openings or cysts in the side of the neck (called branchial cleft fistulae or cysts) and differences in the outer, middle, or inner ear. Because of these ear changes, they have hearing loss, which may be conductive (sound cannot pass well through the ear canal or middle ear), sensorineural (the inner ear or nerve is affected), or mixed (both). Some people also have small internal ear canals (internal auditory canal hypoplasia), eye alignment problems (strabismus), tight jaw opening (trismus), curved or short fifth fingers, light patches of skin (vitiligo), short stature, and mild learning difficulties. Importantly, in this specific syndrome kidneys and ureters are reported to be normal, which helps separate it from related disorders that include kidney problems. Genetic Rare Diseases Info Center

Branchiogenic deafness syndrome is a genetic condition that affects parts of the neck (branchial arches) and the ears. Many people have small pits or tags in front of the ears, cysts or small channels (fistulas) in the side of the neck, and hearing loss that can be conductive, sensorineural, or mixed. Some families also have kidney changes (this wider spectrum is called BOR). The condition is usually autosomal dominant, so one changed copy of a gene can cause the disorder. Most cases relate to changes in EYA1, SIX1, or SIX5 genes. Early hearing care, speech-language support, and surgery for neck cysts or ear canal problems are the mainstays of care. MedlinePlus+3NCBI+3Genetic Rare Diseases Info Center+3

How common and how it presents. Hearing loss happens in most affected people, but the type and severity vary a lot. Mixed hearing loss is frequently reported, and ear imaging may show middle or inner-ear differences. Neck findings (branchial cysts/fistulas) can become infected and may need surgery. In BOR, kidney findings range from mild structural changes to reflux or reduced function, so periodic kidney checks are recommended. Nature+2NCBI+2

This condition is so rare that it has been described in one large family. Doctors think it is genetic and usually autosomal dominant (one changed copy of a gene is enough), but the exact gene is not firmly known yet. Genetic Rare Diseases Info Center+1

---

Other names

• Branchiogenic hearing loss syndrome

• Mégarbané–Loiselet syndrome (named after the first detailed report) Genetic Rare Diseases Info Center+1

---

Types

There is no official subtype system because the syndrome is extremely rare. In day-to-day care, clinicians usually “type” cases by what is most affected:

1. By hearing pattern

   • Conductive type: mainly middle-ear or ear-canal problems block sound.

   • Sensorineural type: inner-ear or nerve problems reduce hearing.

   • Mixed type: both are present. Genetic Rare Diseases Info Center

2. By branchial (neck) changes

   • Cyst-predominant: one or more branchial cysts.

   • Fistula-predominant: a small opening on the neck with a tract. Genetic Rare Diseases Info Center

3. By associated findings

   • With craniofacial/limb features (strabismus, trismus, fifth-finger changes).

   • Minimal associated features (ear + branchial findings only). Genetic Rare Diseases Info Center

In all types above, kidney abnormalities are not expected, unlike the related branchio-oto-renal spectrum where kidneys can be involved. NCBI+1

---

Causes

Because the exact gene is not yet confirmed for this specific syndrome, the “causes” below explain how and why it can happen, based on what is known for this syndrome and closely related conditions that affect the same embryologic pathway.

1. Autosomal dominant genetic change (pathogenic variant). One altered copy of a gene is likely enough to cause the syndrome in a family. Genetic Rare Diseases Info Center

2. A new (de novo) variant in the child. The change may appear for the first time in the affected child with no family history. MedlinePlus

3. Haploinsufficiency. Losing function of one copy of a key developmental gene can disrupt normal ear and branchial arch development. (This mechanism is proven in related BOR/BOS conditions.) NCBI

4. Missense variant. A single “letter” change alters one amino acid in a key protein and impairs its function. (Common mechanism in BOR/BOS genes.) MedlinePlus

5. Nonsense or frameshift variant. A change that truncates the protein early, preventing normal function. (Seen in related disorders.) NCBI

6. Splice-site variant. A change that prevents correct processing of the gene’s RNA, reducing or altering protein made. (Known in BOR/BOS.) NCBI

7. Copy-number deletion. Loss of a segment containing a critical gene can cause the phenotype. (Copy-number changes are well documented in the overlapping spectrum.) MedlinePlus

8. Copy-number duplication. Gaining extra copies can disturb dosage-sensitive developmental programs. (Reported in BOR-like presentations.) NCBI

9. Regulatory-region variant. A change in switches that turn genes on/off during neck and ear development may mimic gene loss. (Documented concept in the spectrum.) NCBI

10. Mosaicism. Only some cells carry the variant, leading to milder or asymmetric features; a mosaic parent can pass a full variant to a child. (General genetic principle recognized in the spectrum.) NCBI

11. Pathway disruption of EYA1–SIX1 network. Although not proven for this exact syndrome, the same embryologic pathway controls ear and second-arch development in BOR/BOS and may be involved. MedlinePlus

12. Unknown/undiscovered gene. Many families with branchio-otic features lack changes in known genes, suggesting additional genes remain to be found. MedlinePlus

13. Modifier genes. Background genetic differences can make features more or less severe within a family. (Explains variable expressivity in the spectrum.) NCBI

14. Embryologic timing effects. A genetic hit early in development can affect both ear and branchial structures that form at the same time. MedlinePlus

15. Epigenetic influences. Changes in gene regulation (not DNA sequence) may influence severity; this is suspected in variable phenotypes. NCBI

16. Digenic/oligogenic models. Two mild variants in interacting genes might together cause disease (proposed in syndromic hearing-loss research). NCBI

17. Parental age effect (possible). New variants can occur more often with advancing parental age (general genetics principle). MedlinePlus

18. Chromosomal rearrangements. Rare structural changes near key genes can disturb their function and produce overlapping features. NCBI

19. Gene–environment interaction (limited). Environment does not cause the syndrome, but illness or noise exposure can worsen hearing once the genetic condition is present. (General hearing-loss guidance.) Iowa Head and Neck Protocols

20. Reduced penetrance in relatives (possible). A parent may carry the variant but show few signs, while a child is more affected (seen across the branchio-otic/renal spectrum). NCBI

---

Symptoms

1. Hearing loss from birth. May be conductive, sensorineural, or mixed; loudness and clarity vary between ears and over time. Genetic Rare Diseases Info Center

2. Branchial cleft cysts. Soft, painless lumps on the side of the neck that can swell or get infected. Genetic Rare Diseases Info Center

3. Branchial fistulae (small neck openings). Tiny pits that may drain fluid; a tract can run under the skin. Genetic Rare Diseases Info Center

4. Outer-ear differences. Small pits or tags in front of the ear; unusual ear shape or position. Genetic Rare Diseases Info Center

5. Narrow or blocked ear canal. Sound cannot pass well, adding conductive hearing loss. NCBI

6. Ossicle (middle-ear bone) differences. The little bones can be small, fixed, or out of place, reducing sound movement. Iowa Head and Neck Protocols

7. Inner-ear malformations. The cochlea or semicircular canals may be under-formed; the internal auditory canal can be small. Genetic Rare Diseases Info Center

8. Tinnitus. Ringing or buzzing due to ear-structure changes. (Common in mixed sensorineural hearing loss.) Iowa Head and Neck Protocols

9. Balance problems. Abnormal semicircular canals can cause unsteadiness or delayed motor milestones. NCBI

10. Strabismus. Eyes do not line up together; may need glasses or therapy. Genetic Rare Diseases Info Center

11. Trismus. Jaw opening is tight or limited, making dental care and eating harder. Genetic Rare Diseases Info Center

12. Abnormal fifth fingers. The little fingers may be bent or shortened. Genetic Rare Diseases Info Center

13. Vitiligo-like patches. Light skin areas may appear on the body. Genetic Rare Diseases Info Center

14. Short stature. Height may be below average. Genetic Rare Diseases Info Center

15. Mild learning difficulties. Some children need extra help in school, often related to hearing access rather than brain injury. Genetic Rare Diseases Info Center

---

Diagnostic tests

A) Physical-exam based (bedside)

1. Head and neck exam. Doctor looks/feels for pits, tracts, or cysts along the front edge of the sternocleidomastoid muscle—classic for second-arch anomalies. NCBI

2. Ear exam (otoscopy). Checks ear canal width and eardrum; can show stenosis, atresia, or chronic infection. NCBI

3. Craniofacial exam. Notes ear shape, facial asymmetry, jaw opening (for trismus), and palate. Iowa Head and Neck Protocols

4. Eye exam (cover test). Screens for strabismus; referral to ophthalmology if present. Genetic Rare Diseases Info Center

5. Skin exam. Looks for vitiligo-like patches that support the pattern. Genetic Rare Diseases Info Center

B) Simple manual/bedside tests

6. Tuning-fork tests (Rinne and Weber). Quickly separates conductive from sensorineural loss at the bedside. (Standard audiology practice.) Iowa Head and Neck Protocols

7. Jaw opening measurement. A ruler or mouth gauge quantifies trismus for monitoring. Genetic Rare Diseases Info Center

8. Bedside vestibular check (head-impulse). Screens semicircular-canal function when balance is a concern. (Common ENT bedside test.) Iowa Head and Neck Protocols

9. Gentle pressure over a neck pit/cyst. May express fluid that suggests a fistula tract; prompts imaging and ENT referral. NCBI

C) Laboratory & pathological tests

10. Newborn hearing screen. Automated screening (OAE/ABR) flags early hearing issues for immediate audiology follow-up. NCBI

11. Genetic testing (hearing-loss panel or exome). Looks for variants in known branchio-otic/renal genes (e.g., EYA1, SIX1, SIX5) or finds new candidate genes; helps confirm inheritance and counsel families. NCBI+1

12. Histopathology of excised branchial cyst/fistula. Confirms a branchial-cleft origin after surgery, rules out other neck masses. NCBI

13. Basic kidney labs (BUN, creatinine, urinalysis). Usually normal here, but they help prove kidneys are unaffected and exclude the broader BOR spectrum. NCBI

D) Electrodiagnostic (ear and balance function)

14. Pure-tone audiometry. Measures hearing thresholds and characterizes conductive vs sensorineural vs mixed loss to guide treatment (hearing aids, surgery, implants). Iowa Head and Neck Protocols

15. Tympanometry. Tests middle-ear pressure and eardrum movement; helps detect conductive elements. Iowa Head and Neck Protocols

16. Otoacoustic emissions (OAE). Screens outer hair-cell function; often used with ABR in infants. NCBI

17. Auditory brainstem response (ABR). Objective test of the hearing nerve pathway; crucial in babies and when testing is hard. NCBI

18. Vestibular evoked myogenic potentials (VEMP) or calorics. Evaluate balance pathways if dizziness or motor delay is present. NCBI

E) Imaging

19. High-resolution temporal-bone CT. Shows ear-canal atresia/stenosis, ossicle malformations, and middle-ear anatomy—essential before surgery. Iowa Head and Neck Protocols

20. MRI of internal auditory canals/brain. Defines small internal auditory canals, cochlear nerve status, and soft-tissue fistula tracts; helps plan hearing devices or branchial surgery. Genetic Rare Diseases Info Center+1

21. Neck ultrasound or contrast study (fistulogram). Maps cysts/tracts to guide safe surgery. Iowa Head and Neck Protocols

22. (Optional) Renal ultrasound. Usually normal in this syndrome; included once to document absence of kidney anomalies and to rule out BOR in the differential. MedlinePlus

Why test the kidneys if they are “not part” of this syndrome? Because related conditions (BOR spectrum) can include kidney/urinary changes. Showing normal kidneys helps confirm the diagnosis and future safety. NCBI

Non-pharmacological treatments (therapies and other measures)

1. Family-centered genetic counseling. Explain inheritance (autosomal dominant), recurrence risks, and testing options for relatives. It helps families plan screening (hearing and kidneys) and make early care decisions. Counseling also supports psychosocial needs and connects families with resources. NCBI+1

2. Lifelong audiology follow-up. Regular hearing tests track changes over time, guide device fitting, and time surgery if needed. Early monitoring prevents language delays and improves educational outcomes. NCBI

3. Hearing aids (air-conduction). For mild to moderate sensorineural or mixed hearing loss, modern digital aids improve speech perception and classroom hearing while preserving residual hearing. Real-ear verification and classroom FM/remote-mic systems optimize benefit. NCBI

4. Bone-anchored hearing systems (BAHS). Useful when the ear canal or middle ear is malformed or chronically infected. A small implant conducts sound through bone to the inner ear, improving speech understanding without using the ear canal. NCBI

5. Cochlear implant candidacy and rehabilitation. For bilateral severe-to-profound sensorineural loss, implants can restore access to sound. A structured program (mapping, auditory training, family coaching) is essential after surgery. NCBI

6. Canaloplasty/meatoplasty (surgical reshaping). When the ear canal is atretic or stenotic, carefully planned surgery can open the canal, reduce infections, and allow better fitting of hearing devices. Decision-making weighs benefits vs. restenosis risk. NCBI

7. Branchial cyst/fistula excision. Recurrent infections, drainage, or cosmetic concerns are treated with complete tract removal to prevent recurrence. Pre-operative imaging helps map the tract and protect nearby nerves. orpha.net

8. Speech-language therapy. Early, play-based therapy strengthens speech, language, and listening skills, especially if hearing loss begins before speech development. Collaboration with the audiology team aligns goals. Nature

9. Auditory-verbal therapy (AVT). Structured listening-first training for children using hearing aids or implants helps brain pathways for hearing and language develop. Parent coaching at home boosts daily progress. Nature

10. Educational accommodations. Seating near the teacher, captioning, real-time transcription, and FM/DM systems cut classroom noise and improve comprehension, closing achievement gaps. Nature

11. Visual communication supports. Signing, cued speech, and captioning provide parallel language access while hearing devices are optimized, protecting literacy and social development. Nature

12. Infection prevention for ears. Dry-ear precautions, gentle cleaning, and avoiding trauma help reduce otitis externa in narrowed or surgically altered ear canals. Early treatment prevents temporary hearing dips. NCBI

13. Kidney monitoring (BOR). Periodic urinalysis, blood pressure checks, and ultrasound when indicated catch reflux or scarring early, guiding nephrology care. NCBI

14. Noise protection. Consistent use of well-fitted ear protection at work, during travel, and at events protects remaining hearing. Education on safe listening habits is vital. Nature

15. Newborn hearing screening + early intervention. For at-risk families, confirm diagnostic testing quickly and enroll in early services to protect language and learning. Nature

16. Psychosocial support. Peer groups, counseling, and family education reduce stigma, improve adherence to devices, and support teen transition to self-care. Nature

17. Multidisciplinary care pathway. Coordinated ENT, audiology, genetics, speech-language, and (if needed) nephrology visits streamline decisions and reduce delays. NCBI

18. Imaging when appropriate. Temporal-bone CT/MRI clarifies middle/inner-ear anatomy before surgery or implants and explains conductive vs. sensorineural components. Nature

19. Avoid known ototoxins when possible. Discuss alternatives to medicines with known ear toxicity; if essential, monitor hearing and kidneys closely. Nature

20. Lifestyle measures for ear health. Smoke-free homes, fitness, hydration, and treating allergies/sinus problems can lower infection risk and improve device comfort. Nature

---

Drug treatments

There is no disease-modifying drug for BO/BOR. Medicines treat complications (ear infections, inflammation, allergies, or kidney issues). Doses below are typical label ranges for adults unless pediatric dosing is stated on the cited FDA label—final dosing must follow the prescriber’s judgment and local guidelines.

1. Ofloxacin otic 0.3% – topical antibiotic for otitis externa/media with tympanostomy tubes. Purpose: clear bacterial ear infections without ototoxic risk associated with some alternatives. Mechanism: fluoroquinolone inhibits DNA gyrase/topoisomerase IV. Common side effects: mild discomfort, pruritus. Usual dosing: label-directed drops for 7–10 days. FDA Access Data+2FDA Access Data+2

2. Ciprofloxacin/dexamethasone otic (CIPRODEX) – antibiotic + steroid for acute otitis media with tubes or otitis externa. Purpose: treat infection and reduce canal inflammation/swelling. Mechanism: ciprofloxacin bactericidal; dexamethasone anti-inflammatory. Side effects: ear pruritus, discomfort; follow drop technique. Dosing: label schedule for 7 days. FDA Access Data+1

3. Ciprofloxacin/hydrocortisone otic (Cipro HC) – similar indication for otitis externa in patients ≥1 year. Mechanism & purpose: as above; hydrocortisone reduces inflammation. Side effects: local irritation; contraindicated with known quinolone/corticosteroid allergy. Dosing: label regimen. FDA Access Data+1

4. Ciprofloxacin otic (Cetraxal) – antibiotic ear drops for otitis externa. Purpose: treat canal infection when steroid not required. Dosing: label directions; stress adherence. FDA Access Data

5. Amoxicillin-clavulanate (AUGMENTIN) – oral antibiotic for acute otitis media or sinusitis when bacterial coverage needed. Purpose: cover β-lactamase producers. Mechanism: amoxicillin inhibits cell wall; clavulanate inhibits β-lactamase. Usual dose: per label/indication and renal function. Side effects: GI upset, rash. FDA Access Data+1

6. Acetaminophen (paracetamol) – analgesic/antipyretic for ear pain/fever. Purpose: comfort and sleep, especially in children. Mechanism: central COX inhibition. Dose: follow label; avoid exceeding daily max. Side effects: rare liver injury with overdose. FDA Access Data+1

7. Ibuprofen – NSAID for pain/inflammation relief during infections or after procedures. Mechanism: COX inhibition. Dosing: use lowest effective dose; pediatric dosing by weight. Warnings: GI, renal risks; pregnancy restriction at ≥20 weeks. FDA Access Data+1

8. Prednisone (e.g., RAYOS delayed-release) – systemic steroid occasionally used in short courses for marked Eustachian edema or as part of protocols for sudden sensorineural hearing loss (case-by-case). Mechanism: anti-inflammatory, immunomodulatory. Risks: glucose, mood, infection masking—use judiciously. FDA Access Data

9. Prednisolone – alternative systemic corticosteroid; dosing and precautions similar. Reserve for specific indications under ENT guidance. FDA Access Data

10. Cetirizine – oral antihistamine for allergic rhinitis that worsens Eustachian dysfunction and ear symptoms. Mechanism: H1 receptor blockade. Common effects: somnolence in some patients. Dose: label directed. FDA Access Data+2FDA Access Data+2

11. Loratadine – non-sedating antihistamine to reduce nasal/ear allergy symptoms; may improve comfort with hearing devices. Dose: per OTC/Rx label. FDA Access Data+2FDA Access Data+2

12. Montelukast – leukotriene receptor antagonist for allergic rhinitis/asthma when indicated. Note: carries a boxed warning for serious neuro-psychiatric events; consider alternatives first in mild disease. Dose: once daily. FDA Access Data+2FDA Access Data+2

13. Topical fluoroquinolone/steroid combinations (class) – broader category guidance for otic infections; follow individual labels for dosing and precautions. FDA Access Data

14. Amoxicillin (plain) – when cultures/susceptibility show no β-lactamase producers, plain amoxicillin may be preferred; follow local guidelines. (Use company/labeled references when prescribed.) FDA Access Data

15. Cephalosporins (e.g., cefdinir) – alternative oral antibiotics for otitis media in penicillin-allergic patients without anaphylaxis history; dosing per label. (Consult the specific FDA label for the chosen agent.) FDA Access Data

16. Clindamycin – option for suspected MRSA or β-lactam allergy, as guided by local resistance patterns and cultures; monitor GI effects. (Use FDA label of product dispensed.) FDA Access Data

17. ACE inhibitor (lisinopril) for BOR with proteinuria/hypertension – kidney-protective effect in proteinuric states; used under nephrology supervision. Not a hearing drug, but reduces renal complications in BOR. FDA Access Data+1

18. ARB (losartan) – alternative to ACE inhibitor when cough/angioedema occurs; monitor potassium and renal function. FDA Access Data+1

19. Intranasal corticosteroid (e.g., fluticasone) – for allergic rhinitis contributing to Eustachian dysfunction; improves nasal obstruction and drainage. (Use the specific product’s FDA label.) Medscape

20. Analgesic ear drops (per label) – short-term comfort in acute ear pain; do not use if tympanic membrane status is uncertain. (Use product’s FDA label.) Medscape

---

Dietary molecular supplements

Important: No supplement cures genetic hearing loss. These nutrients may support overall ear or nerve health in selected contexts. Discuss with clinicians and avoid excess dosing.

1. Magnesium. May help inner-ear hair cells tolerate stress; studied for noise exposure. Typical diet provides 300–400 mg/day; supplemental dosing individualized. Too much can cause diarrhea and, rarely, low blood pressure in kidney disease. Office of Dietary Supplements

2. Zinc. Supports immune function and wound healing; deficiency can impair taste/smell and infection defense. Excess zinc may lower copper and cause GI upset. Dosing should respect upper limits. Office of Dietary Supplements

3. Vitamin D. Supports bone (ossicles/skull base) and immune function; deficiency is common and correctable. Supplement only to targets, as excess causes hypercalcemia. Office of Dietary Supplements

4. N-acetylcysteine (NAC). Antioxidant studied for noise-related hearing risk; human evidence is mixed, with some meta-analyses suggesting possible small protective effects and others finding limited benefit. Use only under guidance. PMC+2PubMed+2

5. Coenzyme Q10. Mitochondrial cofactor; small studies suggest potential benefit in specific mitochondrial-related hearing problems; overall evidence is preliminary. PMC+1

6. Folate/B-complex. Correcting deficiency supports neural development and may improve anemia-related fatigue that worsens listening effort; use standard dietary doses. (General nutrition guidance.) Medscape

7. Omega-3 fatty acids. Heart-healthy fats that may benefit microvascular health; supportive for general wellness; choose food sources first. (General nutrition guidance.) Medscape

8. Vitamin A (avoid excess). Essential for epithelial health; maintain recommended intake only—excess is harmful. (General nutrition guidance.) Medscape

9. Vitamin C. General antioxidant support; excessive dosing may cause GI upset or kidney stones in predisposed individuals; food-first approach preferred. (General nutrition guidance.) Medscape

10. Vitamin E. Antioxidant; avoid high-dose supplements unless a clinician recommends them due to bleeding risk with anticoagulants. (General nutrition guidance.) Medscape

---

Immunity-booster / regenerative / stem cell drugs

Plain truth: *There are currently *no FDA-approved stem cell or “regenerative” drugs for hearing loss, BO, or BOR. Be cautious with clinics advertising stem cells or exosomes; the FDA warns that many such products are unapproved and potentially unsafe. Instead, families should focus on evidence-based prevention (vaccines, infection control) and supportive therapies listed above. U.S. Food and Drug Administration+2U.S. Food and Drug Administration+2

Safer, evidence-based supportive measures (not stem cells):

1. Routine vaccines (influenza, pneumococcal as indicated). Reduces ear and respiratory infections that can trigger hearing dips. (Use national immunization guidelines.) Nature

2. Allergy control plan (environmental + labeled meds). Lowers Eustachian tube swelling and secondary ear infections. Nature

3. Prompt, guideline-based treatment of otitis media/externa. Prevents complications and conductive hearing loss episodes. NCBI

4. Noise-exposure management. Protects remaining cochlear function; complements devices and surgery. Nature

5. Kidney-protective therapy in BOR (ACEi/ARB when indicated). Slows kidney damage—an important part of “whole-person” care. FDA Access Data+1

6. Rehab-driven neuroplasticity (AVT, speech-language, consistent device use). Builds auditory pathways—our best “regenerative” strategy today. Nature

---

Surgeries (procedure & why it’s done)

1. Branchial cyst/fistula excision. Complete removal of the cyst and its tract treats infections, prevents recurrence, and improves neck appearance. Imaging and careful dissection protect nearby nerves and vessels. orpha.net

2. Canaloplasty/meatoplasty. Reshapes or opens a narrowed/blocked ear canal to reduce infections and allow sound/earmold access. Chosen when anatomy and hearing goals support benefit. NCBI

3. Ossicular chain reconstruction. For conductive components due to ossicular malformations or fixation, reconstruction can improve sound transmission to the inner ear. Decision depends on CT findings and hearing goals. Nature

4. Bone-anchored hearing system (BAHS) implantation. For external/middle-ear malformations or chronic drainage, BAHS directly stimulates the cochlea via skull bone, improving audibility. NCBI

5. Cochlear implantation. For severe-to-profound sensorineural loss, an internal electrode array stimulates the auditory nerve. Post-op programming and therapy are essential for speech understanding. NCBI

---

Preventions (day-to-day)

1. Schedule regular hearing tests and device checks. NCBI

2. Protect from loud noise at work, school, and events. Nature

3. Treat ear infections early and finish prescribed drops/antibiotics. FDA Access Data

4. Allergy control (environmental + labeled meds) to reduce Eustachian swelling. Medscape

5. Avoid ototoxic drugs where alternatives exist; monitor if unavoidable. Nature

6. Kidney check-ups in BOR (urine, BP, labs/ultrasound when needed). NCBI

7. Vaccinations to reduce respiratory/ear infections. Nature

8. Smoke-free home to cut ear infection risk in children. Nature

9. Genetic counseling for family planning and cascade testing. Nature

10. Safe listening education for teens (limit headphone volume/time). Nature

---

When to see doctors (red flags)

See an ENT/audiologist promptly for sudden hearing drop, persistent ear pain/drainage, rapid feedback or malfunction of devices, or dizziness with new ear symptoms. Families with BOR should see nephrology if swelling, high blood pressure, blood or protein in urine, or urinary infections occur. Seek genetics if a new baby in the family needs targeted screening or if relatives have ear pits/tags or hearing loss. Early review prevents complications and keeps language development on track. NCBI+1

---

What to eat and what to avoid

What to eat. Focus on balanced meals with fruits, vegetables, whole grains, lean proteins, dairy or fortified alternatives, and sources of magnesium, zinc, and vitamin D (e.g., nuts/seeds, legumes, oily fish, eggs, fortified milk). Hydration helps mucus clearance. These choices support general and ear health and reduce infection risk factors. Office of Dietary Supplements+2Office of Dietary Supplements+2

What to avoid. Do not exceed supplement upper limits without medical advice (e.g., zinc, vitamin A, vitamin D). Limit alcohol and avoid tobacco exposure. Avoid unnecessarily high-dose NSAIDs without clinician guidance, especially in those with kidney concerns. Be skeptical of “ear cure” supplements or unapproved stem cell/exosome ads. U.S. Food and Drug Administration+3Office of Dietary Supplements+3Office of Dietary Supplements+3

---

Frequently asked questions

1. Is this condition inherited? Yes—usually autosomal dominant; each child has a 50% chance if a parent is affected. Genetic Rare Diseases Info Center

2. Which genes are involved? Most often EYA1, SIX1, SIX5. Genetic Rare Diseases Info Center

3. Does everyone get kidney problems? No. If kidneys are normal it’s BO; with kidney findings it’s BOR. Screening is still wise. MedlinePlus

4. What kind of hearing loss happens? Mixed is common; sensorineural or conductive also occur. Nature

5. Can hearing improve with time? Hearing usually needs devices/surgery; stable vs. changing patterns vary by person. Follow-up is key. NCBI

6. Are there medicines that cure it? No. Medicines treat infections or inflammation and support comfort. NCBI

7. Are stem cells approved for hearing loss? No—avoid unapproved clinics. U.S. Food and Drug Administration

8. Can children develop normal speech? Yes—with early hearing management and therapy. Nature

9. When is surgery needed? For branchial cysts/fistulas, canal problems, or specific middle/inner-ear issues after imaging. orpha.net

10. Are cochlear implants an option? Yes, for severe-to-profound sensorineural loss with rehab afterward. NCBI

11. What about school? Classroom supports (FM/DM, captions, seating) and IEP/504 plans help learning. Nature

12. Do allergies matter? Yes—controlling rhinitis can reduce ear pressure problems. Medscape

13. Should family members be tested? Often yes—discuss cascade testing and hearing/kidney screening in relatives. Nature

14. Is imaging required? Sometimes—CT/MRI helps plan surgery or implants. Nature

15. How often should hearing be checked? Regularly; your audiologist sets the schedule (often every 6–12 months, more often in childhood). Nature

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: November 02, 2025.